Related Experiment Videos
Interferon therapy in neoplastic disease. A preliminary report
Acta Medica Scandinavica
|January 1, 1978
Summary
This study explored interferon therapy for neoplastic disease in 10 patients. Interferon treatment showed potential benefits, including partial regression in bladder papilloma cases, with minimal side effects.
Area of Science:
- Immunology
- Oncology
Background:
- Exogenous interferon therapy is being investigated for neoplastic diseases.
- Partially purified human leukocyte interferon, induced by Sendai virus, was administered intramuscularly.
Observation:
- Ten patients with neoplastic disease received interferon therapy for 2-28 months.
- Initial fever was the only noted side effect.
- Patients with bladder papillomas experienced partial regression.
Findings:
- Interferon therapy demonstrated potential benefits in treating neoplastic conditions.
- Partial regression was observed in bladder papilloma patients after several months of treatment.
Implications:
- Exogenous interferon therapy may offer a viable treatment option for certain neoplastic diseases.
- Further research is warranted to confirm the efficacy and scope of interferon therapy in oncology.